Health Care: Drugs

Imprimis Pharmaceuticals Inc (IMMY: NASDAQ)

$6.87 -0.12 | -1.72%
04/17/14 - 11:35 AM ET
Company Profile
Price and Volume
Recent Price 6.99
52 Week High 10.00
52 Week Low 3.01
Avg. Daily Vol. (Mil) 0.06
Beta (3 year) -2.02
Share Related Items
Mkt Cap (Mil) 63.51
Shares Out (Mil) 9.09
Float (Mil) 6.63
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 24.00
Current Ratio 24.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 6.35K
Price/Book 4.20
Price/Cash Flow -8.60
Per Share Data
Earnings -0.88
Sales 0.00
Book Value 1.66
Cash Flow -0.81
Business Summary
Imprimis Pharmaceuticals Inc is a development stage pharmaceutical company developing non-invasive, topically delivered products.
General Information
437 South Highway 101
Suite 209
Solana Beach, CA 92075
www.imprimispharma.com
Industry : Drugs
Sector: Health Care
Employees: 17
CEO: Mark L. Baum
Short Interest
Current Month (Mil) 0.06
Previous Month (Mil) 0.04
Short Interest Ratio (Days) 1.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -48.50
Return on Investments -50.60
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with IMMY

Latest IMMY Headlines from TheStreet

More Financial News for IMMY

Press Releases for IMMY

See All Press Releases

Partner Headlines for IMMY

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter